We are live on ! Find out more
MGNX icon

MacroGenics

122 hedge funds and large institutions have $266M invested in MacroGenics in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 45 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 21

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.05% less ownership

Funds ownership: 92.91%91.86% (-1%)

2% less funds holding

Funds holding: 124122 (-2)

17% less call options, than puts

Call options by funds: $380K | Put options by funds: $456K

29% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 45

46% less capital invested

Capital invested by funds: $495M → $266M (-$229M)

Holders
122
Holders Change
-2
Holders Change %
-1.61%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
32
Reduced
45
Closed
21
Calls
$380K
Puts
$456K
Net Calls
-$76K
Net Calls Change
-$4.97M

MGNX Hedge Fund Activity: Q1 2020 in Review

122 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2020, worth a combined $266M — down 46% from $495M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new MGNX positions and 21 closed out — a net gain of 1 holder — while 32 added to existing stakes and 45 trimmed.

The largest buyer was Ameriprise, adding an estimated $4.33M. The largest seller was Sofinnova Investments, exiting entirely with an estimated $12.8M sold.

  • 122 institutional investors held MacroGenics (MGNX) as of Q1 2020, down from 124 in Q4 2019.
  • Funds reported $266M of MacroGenics stock for Q1 2020, down 46% quarter-over-quarter.
  • 22 funds opened new MacroGenics positions in Q1 2020 and 21 closed out, a net change of +1 holder.
  • The largest MacroGenics buyer in Q1 2020 was Ameriprise, an estimated $4.33M added.
  • The largest MacroGenics seller in Q1 2020 was Sofinnova Investments, an estimated $12.8M sold.

Based on aggregated 13F filings for Q1 2020.